Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This reflects a minor update to the published page without altering the study content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision line changed from v3.5.3 to v3.5.4, indicating a new release of the page content. This update reflects a metadata or maintenance release rather than a substantive change to the page's information.SummaryDifference0.1%

- Check49 days agoChange DetectedThis update refreshes the website’s version/revision footer from v3.5.2 to v3.5.3 without changing the study record content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe website revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check70 days agoChange DetectedNew and removed entry dates were added to the study record, with the latest update posted on 2026-03-27.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision log updated: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.